Skip to main content
. 2020 Aug 15;12(8):2293. doi: 10.3390/cancers12082293

Table 4.

Pharmacokinetics of Tenalisib.

Parameter 200 mg BID 400 mg BID 800 mg BID 800 mg BID (fed)
C1D1 C2D1 C1D1 C2D1 C1D1 C2D1 C1D1 C2D1
Cmax * (ng/mL) 1297.3 1651.4 2196.7 2897.7 3995.7 3231.5 2668.0 4165.6
AUC0–∞ * (h * ng/mL) 3538.3 4018.0 6530.9 5603.9 17,363.7 17,159.4 14,538.5 14,233.8
AUC(0-τ) * (h * ng/mL) 3503.0 3970.8 6415.5 5526.8 16,424.2 16,200.3 13,591.2 13,555.3
Tmax # (h) 1.0 0.5 0.8 0.5 1.1 2.1 2.1 1.1
t1/2 * (h) 1.6 1.8 1.9 2.0 2.6 2.6 2.6 2.8
λz (h−1) 0.4 0.4 0.4 0.4 0.3 0.3 0.3 0.3

Cmax = Maximum plasma concentration; AUC0-∞ = Area under the curve to infinity; AUC(0-τ) = Area under the plasma concentration-time curve from time of administration to the end of the dosing interval; Tmax = Time taken to reach maximum concentration; t1/2 = Elimination half-life. λz = Apparent terminal elimination rate constant; BID = Twice a day; C = Cycle; D = Day. * Geometric mean; # Median.